DPDavid J. Paterson

David J. Paterson

*This is an algorithmically generated author record based on publicly available information.

David J. Paterson has a total of 72 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Howard Florey and neuroscience

    by Geoffrey A. Donnan, David J. Paterson

  • Long‐term effect of neuronal nitric oxide synthase over‐expression on cardiac neurotransmission mediated by a lentiviral vector

    by Lijun Wang, Dan Li, Tom A. Dawson, David J. Paterson

    Short-term over-expression of neuronal nitric oxide synthase (nNOS) with adenoviral gene transfer into peripheral cardiac autonomic neurons can facilitate cholinergic neurotransmission, and inhibit sympathetic transmission, by regulating cyclic nucleotide-dependent pathways coupled to neuronal calcium entry. We tested the idea whether cardiac neuromodulation by nNOS could be sustained by long-term over-expression of the enzyme following lentiviral gene transfer. We developed a lentiviral vector with an elongation factor 1 (EF1alpha) promoter to drive nNOS or enhanced green fluorescent protein (eGFP) expression. Lenti.EF1alpha-nNOS or Lenti.EF1alpha-eGFP was transferred to the right atrium of Spague-Dawley (SD) rats and acetylcholine (ACh) or noradrenaline (NA) release to field stimulation was measured 4 months after gene transfer. Atria transduced with Lenti.EF1alpha-nNOS had higher nNOS expression compared to the atria treated with Lenti.EF1alpha-eGFP (P < 0.05). We also detected significant increases (P < 0.05) in atrial cGMP and cAMP levels in the same tissue. Immunohistochemistry revealed co-localisation of eGFP in intrinsic cholinergic neurons (choline acetyltransferase positive) and intrinsic adrenergic neurons (tyrosine hydroxylase positive) following gene transfer. nNOS-transduced animals displayed enhanced ACh release (P < 0.05) and reduced NA release (P < 0.05) compared to the eGFP-treated group. nNOS-specific inhibition reversed the enhanced ACh release. Persistent nNOS over-expression mediated by a lentiviral vector can modulate sympatho-vagal control of cardiac excitability. This approach may provide a new tool to target impaired cardiac autonomic phenotypes that are disrupted by several cardiovascular pathologies.


  • Noradrenergic Cell Specific Gene Transfer With Neuronal Nitric Oxide Synthase Reduces Cardiac Sympathetic Neurotransmission in Hypertensive Rats

    by Dan Li, Lijun Wang, Chee-Wan Lee, Tom A. Dawson, David J. Paterson

    Nitric oxide–cGMP pathway can inhibit cardiac norepinephrine (NE) release. Sympathetic hyper-responsiveness in hypertension may result from oxidative stress impairing this pathway. We tested the hypothesis that the gene transfer of neuronal NO synthase (nNOS) could restore sympathetic balance in the spontaneously hypertensive rat (SHR). An adenovirus (5×10 10 particles) constructed with a noradrenergic neuron-specific promoter (PRS ×8) encoding nNOS (Ad.PRS-nNOS) or enhanced green fluorescence protein (Ad.PRS-eGFP) was targeted to the right atrial wall by percutaneous injection in age-matched male SHRs and Wistar-Kyoto (WKY) rats. Five days after transduction, right atria were removed, and evoked [ 3 H] norephinephrine (NE) release, NOS activity, and cGMP were measured. In the Ad.PRS-eGFP treated group, tissue levels of cGMP were significantly lower in the SHR compared with the WKY atria. NE release was also greater in the SHR, and soluble guanylate cyclase inhibition did not alter evoked [ 3 H] NE release in the Ad.PRS-eGFP–treated SHR. All atria treated with Ad.PRS-nNOS had enhanced nNOS activity when compared with Ad.PRS-eGFP atria. Ad.PRS-nNOS in WKY rats reduced NE release compared with the Ad.PRS-eGFP group. Guanylate cyclase inhibition enhanced NE release in both Ad.PRS-nNOS– and Ad.PRS-eGFP–treated WKY atria. Ad.PRS-nNOS restored cGMP levels in the SHR to those seen in the WKY atria. In the SHR, Ad.PRS-nNOS also attenuated NE release compared with Ad.PRS-eGFP group. This was reversed by guanylate cyclase inhibition. We conclude that artificial upregulation of sympathetic nNOS via gene transfer with a noradrenergic promoter may provide a novel approach for correcting peripheral sympathetic hyperactivity in hypertension.


  • Gene Transfer of Neuronal Nitric Oxide Synthase into Intracardiac Ganglia Reverses Vagal Impairment in Hypertensive Rats

    by Daniel A. Heaton, Dan Li, Susanna C. Almond, Tom A. Dawson, Lijun Wang, Keith M. Channon, David J. Paterson

    Hypertension is associated with reduced cardiac vagal activity and decreased atrial guanylate cyclase and cGMP levels. Neuronal production of NO facilitates cardiac parasympathetic transmission, although oxidative stress caused by hypertension may disrupt this pathway. We tested the hypothesis that peripheral vagal responsiveness is attenuated in the spontaneously hypertensive rat (SHR) because of impaired NO-cGMP signaling and that gene transfer of neuronal NO synthase (nNOS) into cholinergic intracardiac ganglia can restore neural function. Cardiac vagal heart rate responses in the isolated SHR atrial/right vagus preparation were significantly attenuated compared with age-matched normotensive Wistar–Kyoto rats. [ 3 H] acetylcholine release was also significantly lower in the SHR. The NO donor, sodium nitroprusside, augmented vagal responses to nerve stimulation and [ 3 H] acetylcholine release in the Wistar–Kyoto rat, whereas the soluble guanylate cyclase inhibitor 1H-(1,2,4)oxadiazolo(4,3-a)quinoxaline-1-one attenuated [ 3 H] acetylcholine release in Wistar–Kyoto atria. No effects of sodium nitroprusside or 1H-(1,2,4)oxadiazolo(4,3-a)quinoxaline-1-one were seen in the SHR during nerve stimulation. In contrast, SHR atria were hyperresponsive to carbachol-induced bradycardia, with elevated production of atrial cGMP. After gene transfer of adenoviral nNOS into the right atrium, vagal responsiveness in vivo was significantly increased in the SHR compared with transfection with adenoviral enhanced green fluorescent protein. Atrial nNOS activity was increased after gene transfer of adenoviral nNOS, as was expression of α 1 -soluble guanylate cyclase in both groups compared with adenoviral enhanced green fluorescent protein. In conclusion, a significant component of cardiac vagal dysfunction in hypertension is attributed to an impairment of the postganglionic presynaptic NO-cGMP pathway and that overexpression of nNOS can reverse this neural phenotype.


  • Identifying cardiorespiratory neurocircuitry involved in central command during exercise in humans

    by Alexander L. Green, Shouyan Wang, Sarah Purvis, Sarah L. F. Owen, Peter G. Bain, John F. Stein, Abe Guz, Tipu Z. Aziz, David J. Paterson

    For almost one hundred years, the exact role of human brain structures controlling the cardiorespiratory response to exercise (‘central command’) has been sought. Animal experiments and functional imaging studies have provided clues, but the underlying electrophysiological activity of proposed relevant neural sites in humans has never been measured. In this study, local field potentials were directly recorded in a number of ‘deep’ brain nuclei during an exercise task designed to dissociate the exercise from peripheral feedback mechanisms. Several patient groups had electrodes implanted sterotaxically for the treatment of movement disorder or chronic pain. Fast Fourier transform analysis was applied to the neurograms to identify the power of fundamental spectral frequencies. Anticipation of exercise resulted in increases in heart rate, blood pressure and ventilation. The greatest neural changes were found in the periaqueductal grey area (PAG) where anticipation of exercise was accompanied by an increase of 43% in the power of the 12–25 Hz frequency band (P= 0.007). Exercise increased the activity by 87% compared to rest (P= 0.006). Changes were also seen in the 60–90 Hz band when anticipation or exercise increased power by 32% (P= 0.006) and 109% (P < 0.001), respectively. In the subthalamic nucleus there was a reduction in the power of the beta frequency during both anticipation (7.6 ± 0.68%P= 0.001) and exercise (17.3 ± 0.96%P < 0.001), whereas an increase was seen with exercise only at higher frequencies (93 ± 1.8%P= 0.007). No significant changes were seen in the globus pallidus during anticipation of exercise. We provide direct electrophysiological evidence highlighting the PAG as an important subcortical area in the neural circuitry of the cardiorespiratory response to exercise, since stimulation of this structure is known to alter blood pressure in awake humans.


  • Reactive Oxygen Species and Autonomic Regulation of Cardiac Excitability

    by Edward J. F. Danson, David J. Paterson

    Sympathetic hyper‐activity and diminished parasympathetic activity are a consequence of many primary cardiovascular disease states and can trigger arrhythmias. Emerging evidence suggests that reactive oxygen species (ROS) including nitric oxide, superoxide, and peroxynitrite may contribute to cardiac sympathovagal imbalance in the brainstem, peripheral neurons, and in cardiomyocytes since all experience increased oxidative stress as a result of cardiac disease processes and aging. This article reviews the roles of ROS in autonomic dysfunction and arrhythmia. In addition, novel research directed toward finding targets for modulating sympathovagal balance in cardiac disease is discussed.


  • Targeting Arterial Chemoreceptor Over-Activity in Heart Failure With a Gas

    by David J. Paterson, Ian C. Wenker, Cleyton R. Sobrinho, Ana C. Takakura, Daniel K. Mulkey, Thiago S. Moreira, Pedro L. Katayama, Jaci A. Castania, Daniel P.M. Dias, Kaushik P. Patel, et al.


  • Impaired regulation of neuronal nitric oxide synthase and heart rate during exercise in mice lacking one nNOS allele

    by E. J. F. Danson, K. S. Mankia, S. Golding, T. Dawson, L. Everatt, S. Cai, K. M. Channon, D. J. Paterson

    We tested the hypothesis that a single allele deletion of neuronal nitric oxide synthase (nNOS) would impair the neural control of heart rate following physical training, and that this phenotype could be restored following targeted gene transfer of nNOS. Voluntary wheel‐running (+EX) in heterozygous nNOS knockout mice (nNOS+/−, +EX; n= 52; peak performance 9.1 ± 1.8 km day−1) was undertaken and compared to wild‐type mice (n= 38; 9.5 ± 0.8 km day−1). In anaesthetized wild‐type mice, exercise increased phenylephrine‐induced bradycardia by 67% (measured as heart rate change, in beats per minute, divided by the change in arterial blood pressure, in mmHg) or pulse interval response to phenylephrine by 52% (measured as interbeat interval change, in milliseconds, divided by the change in blood pressure). Heart rate changes or interbeat interval changes in response to right vagal nerve stimulation were also enhanced by exercise in wild‐type atria (P < 0.05), whereas both in vivo and in vitro responses to exercise were absent in nNOS+/− mice. nNOS inhibition attenuated heart rate responses to vagal nerve stimulation in all atria (P < 0.05) and normalized the responses in wild‐type, +EX with respect to wild‐type with no exercise (−EX) atria. Atrial nNOS mRNA and protein were increased in wild‐type, +EX compared to wild‐type, −EX (P < 0.05), although exercise failed to have any effect in nNOS+/− atria. In vivo nNOS gene transfer using adenoviruses targeted to atrial ganglia enhanced choline acetyltransferase–nNOS co‐localization (P < 0.05) and increased phenylephrine‐induced bradycardia in vivo and heart rate responses to vagal nerve stimulation in vitro compared to gene transfer of enhanced green fluorescent protein (eGFP, P < 0.01). This difference was abolished by nNOS inhibition (P < 0.05). In conclusion, genomic regulation of NO bioavailability from nNOS in cardiac autonomic ganglia in response to training is dependent on both alleles of the gene. Although basal expression of nNOS is normal, polymorphisms of nNOS may interfere with neural regulation of heart rate following training. Targeted gene transfer of nNOS can restore this impairment.


  • Open Access

    Enhanced neuronal nitric oxide synthase expression is central to cardiac vagal phenotype in exercise‐trained mice

    by E. J. F Danson, D. J. Paterson

    We investigated whether enhanced cardiac vagal responsiveness elicited by exercise training is dependent on neuronal nitric oxide synthase (NOS‐1), since the NO‐cGMP pathway facilitates acetylcholine release. Isolated atria with intact right vagal innervation were taken from male mice (18‐22 weeks old) after a period of 10 weeks voluntary wheel‐running (+EX, n= 27; peaked 9.8 ± 0.6 km day−1 at 5 weeks), and from mice housed in cages without wheels (‐EX, n= 27). Immunostaining of whole atria for NOS‐1 identified intrinsic neurones, all of which co‐localized with choline acetyltransferase‐positive ganglia. Western blot analysis confirmed that NOS‐1 protein level was significantly greater in +EX compared to ‐EX atria (P < 0.05, unpaired t test). Basal heart rates (HR) were slower in +EX than in ‐EX atria (322 ± 6 versus 360 ± 7 beats min−1; P < 0.05, unpaired t test) However, in +EX atria, HR responses to vagal stimulation (VNS, 3 and 5 Hz) were significantly enhanced compared to ‐EX atria (3 Hz, +EX: −76 ± 8 beats min−1versus ‐EX: −62 ± 7 beats min−1; 5 Hz, +EX: −106 ± 4 beats min−1versus ‐EX: −93 ± 3 beats min−1; P < 0.01, unpaired t test). Inhibition of NOS‐1 with vinyl‐l‐N‐5‐(1‐imino‐3‐butenyl)‐l‐ornithine (l‐VNIO, 100 μm) or soluble guanylyl cyclase with 1H‐[1, 2, 4]oxadiazolo[4, 3‐a]quinoxalin‐1‐one (ODQ, 10 μm) abolished the difference in HR responses to VNS between +EX and ‐EX atria, and effects of l‐VNIO were reversed by excess l‐arginine (1 mm; P < 0.01, ANOVA). There were no differences between the HR responses to the bath‐applied acetylcholine analogue carbamylcholine chloride in +EX and ‐EX atria (IC50 concentrations were 5.9 ± 0.4 μm (‐EX) and 5.7 ± 0.4 μm (+EX)), suggesting that the changes in vagal responsiveness resulted from presynaptic facilitation of neurotransmission. In conclusion, NOS‐1 appears to be a key protein in generating the cardiac vagal gain of function elicited by exercise training.